GSA Capital Partners’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
GSA Capital Partners's RGC Position: Q3 2026 in Review
GSA Capital Partners opened a new position in Regencell Bioscience (RGC) in Q3 2026: 38,925 shares worth $242K. The stake represents 0.01% of the portfolio and ranks #1501 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in RGC as recently as Q1 2026.
GSA Capital Partners first reported a position in RGC in Q1 2026 and has held it in 2 quarters since. The position peaked at $803K in Q1 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- GSA Capital Partners held 38,925 shares of Regencell Bioscience worth $242K as of Q3 2026.
- Regencell Bioscience was a new GSA Capital Partners position in Q3 2026.
- Regencell Bioscience made up 0.01% of GSA Capital Partners's portfolio in Q3 2026, its #1501 holding.
- GSA Capital Partners first reported a position in Regencell Bioscience in Q1 2026 and has held it in 2 quarters since.
- GSA Capital Partners's Regencell Bioscience position peaked at $803K in Q1 2026.
- 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.